Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients.

Florian J, Garnett CE, Nallani SC, Rappaport BA, Throckmorton DC.

Clin Pharmacol Ther. 2012 Apr;91(4):666-72. doi: 10.1038/clpt.2011.273. Epub 2012 Feb 29.

PMID:
22378153
2.

Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.

Roy AK, McCarthy C, Kiernan G, McGorrian C, Keenan E, Mahon NG, Sweeney B.

Addiction. 2012 Jun;107(6):1132-9. doi: 10.1111/j.1360-0443.2011.03767.x. Epub 2012 Feb 28.

PMID:
22168435
3.

Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.

Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS.

Pharmacotherapy. 2003 Jun;23(6):802-5.

PMID:
12820821
4.

Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?

Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.

Drug Alcohol Rev. 2011 Jul;30(4):388-96. doi: 10.1111/j.1465-3362.2010.00237.x. Epub 2010 Sep 6.

PMID:
21355918
5.

QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.

Perrin-Terrin A, Pathak A, Lapeyre-Mestre M.

Fundam Clin Pharmacol. 2011 Aug;25(4):503-10. doi: 10.1111/j.1472-8206.2010.00871.x. Epub 2010 Sep 6.

PMID:
20825488
6.
7.

Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.

Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):88-93. doi: 10.1016/j.drugalcdep.2012.09.016. Epub 2012 Oct 16.

PMID:
23084592
8.

Prevalence of long QTc interval in methadone maintenance patients.

Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):327-32. doi: 10.1016/j.drugalcdep.2008.06.018. Epub 2008 Sep 5.

PMID:
18774239
9.

Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.

Fareed A, Patil D, Scheinberg K, Blackinton Gale R, Vayalapalli S, Casarella J, Drexler K.

J Addict Dis. 2013;32(3):244-51. doi: 10.1080/10550887.2013.824333.

PMID:
24074190
10.

Onsite QTc interval screening for patients in methadone maintenance treatment.

Fareed A, Vayalapalli S, Byrd-Sellers J, Casarella J, Drexler K, Amar R, Smith-Cox J, Lutchman TS.

J Addict Dis. 2010 Jan;29(1):15-22. doi: 10.1080/10550880903436044.

PMID:
20390695
11.
12.

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.

Pearson EC, Woosley RL.

Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):747-53.

PMID:
15918160
13.

Ventricular arrhythmias in patients treated with methadone for opioid dependence.

Hanon S, Seewald RM, Yang F, Schweitzer P, Rosman J.

J Interv Card Electrophysiol. 2010 Jun;28(1):19-22. doi: 10.1007/s10840-009-9465-9. Epub 2010 Feb 23.

PMID:
20177760
14.

QTc interval prolongation associated with intravenous methadone.

Kornick CA, Kilborn MJ, Santiago-Palma J, Schulman G, Thaler HT, Keefe DL, Katchman AN, Pezzullo JC, Ebert SN, Woosley RL, Payne R, Manfredi PL.

Pain. 2003 Oct;105(3):499-506.

PMID:
14527710
15.

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.

Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H.

Addiction. 2009 Jun;104(6):993-9. doi: 10.1111/j.1360-0443.2009.02549.x. Epub 2009 Apr 9.

PMID:
19392907
16.

Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.

Ehret GB, Voide C, Gex-Fabry M, Chabert J, Shah D, Broers B, Piguet V, Musset T, Gaspoz JM, Perrier A, Dayer P, Desmeules JA.

Arch Intern Med. 2006 Jun 26;166(12):1280-7.

PMID:
16801510
17.

QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.

Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, Guma JR, Segura F.

Am J Cardiol. 2003 Oct 15;92(8):995-7.

PMID:
14556883
18.

Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.

Peles E, Linzy S, Kreek MJ, Adelson M.

J Addict Med. 2013 Nov-Dec;7(6):428-34. doi: 10.1097/ADM.0b013e3182a8a4f2.

PMID:
24145160
19.

Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc interval.

Ansermot N, Albayrak O, Schläpfer J, Crettol S, Croquette-Krokar M, Bourquin M, Déglon JJ, Faouzi M, Scherbaum N, Eap CB.

Arch Intern Med. 2010 Mar 22;170(6):529-36. doi: 10.1001/archinternmed.2010.26.

PMID:
20308640
20.

QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.

Fareed A, Vayalapalli S, Scheinberg K, Gale R, Casarella J, Drexler K.

Am J Drug Alcohol Abuse. 2013 Jul;39(4):235-40. doi: 10.3109/00952990.2013.804525. Epub 2013 Jun 28.

PMID:
23808912

Supplemental Content

Support Center